Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial
暂无分享,去创建一个
M. Parmar | M. Sydes | D. Dearnaley | C. Parker | J. Bono | N. James | N. Clarke | M. Mason | D. Aebersold | G. Thalmann | J. Russell | A. Ritchie | Malcolm D. Mason | Christopher C. Parker | Matthew R. Sydes | Noel W. Clarke | Daniel Aebersold | Johann S. Bono | David P. Dearnaley | Alastair W.S. Ritchie | J. Martin Russell | George Thalmann | Mahesh K.B. Parmar | Nicholas D. James
[1] M. Parmar,et al. Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial , 2011, Trials.
[2] N. Munshi,et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.
[3] T. Ragg,et al. Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Bethan Psaila,et al. The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.
[5] M. Parmar,et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial , 2011, The Lancet.
[6] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[7] R. Sylvester,et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.
[8] A. S. Kibel. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial , 2009 .